Oxford Global are proud to present the Biotherapeutics Event of 2014. Held on 3rd & 4th April 2014 at the Novotel London West, UK the 7th Annual Proteins & Antibodies Congress, the 2nd Annual Biosimilars & Biobetters Congress and the Peptides Congress is not to be missed! Come and join over 400 attendees working within the biotherapeutics industry.

7th Annual Proteins & Antibodies Congress

As the only conference to bring together all the experts in the biopharmaceutical industry, this exciting and important meeting is a must for anyone working in the field of proteins & antibodies.

The Proteins & Antibodies Congress covers the key challenges and critical opportunities in protein purification, expression and characterisation, antibody discovery, development, engineering, bispecific antibodies and antibody drug conjugates. Gain insight and discover innovative solutions to the challenges of biotherapeutics optimisation, scaffold development and immunogenicity testing.

Click here to download the agenda.

2nd Annual Biosimilars & Biobetters Congress

Over two days, this event will attract over 175 senior-level decision makers working in Biosimilars and Biobetters from Europe, the US and Asia. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.

The 2nd Annual Biosimilars & Biobetters Congress covers the key challenges in gaining access to emerging markets and branding follow on biologics, as well as featuring clinical trial case studies and exploring the critical issues in developing biosimilars.

Click here to download the agenda.

Peptides Congress

The Peptides Congress provides a platform for our world renowned industry experts to discuss the latest advancements in the field of peptide research. The Congress will cover a range of topics, from discovery and synthesis through to design, engineering and optimisation techniques. Our esteemed speakers will explore in detail areas such as peptide libraries and array technologies, peptide synthesis and protein-protein interactions, as well as focusing on areas such as optimal peptide design, cell penetrating peptides and peptide-based drug discovery. This will allow participants a thorough insight into this revitalised therapeutic area.

Click here to download the agenda.

Contact Danielle Dalby at d.dalby@oxfordglobal.co.uk for information on attendance.